|
|||||
|
|
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis |
|
| Authors: | Maini R N Taylor P C Paleolog E Charles P Ballara S Brennan F M Feldmann M |
| Affiliation: | The Kennedy Institute of Rheumatology and Imperial College School of Medicine, London. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |